This is a routine insider sale of shares acquired through equity compensation. The amount is immaterial relative to CME's market cap. Monitor for any subsequent Form 4 filings to confirm execution, but no significant market impact is expected.
Price Chart
Executive Summary
Sunil Cutinho, an officer of CME Group, filed a Form 144 notice of intent to sell 5,000 shares of common stock with an approximate market value of $1.49 million. The shares were acquired through performance share and restricted stock grants earlier in 2026. The sale is scheduled for October 27, 2026, and represents a small fraction of CME's $109.9 billion market cap.
Key Facts
- Sunil Cutinho, an officer of CME Group, filed Form 144 to sell 5,000 shares of common stock.
- The estimated market value of the proposed sale is $1,493,500.50.
- The shares were acquired from performance shares (4,598 shares on 03/15/2026) and restricted stock (402 shares on 09/15/2026).
- The sale is proposed to occur on October 27, 2026, through Morgan Stanley Smith Barney LLC.
- CME Group has a market capitalization of approximately $109.9 billion.
Financial Impact
Proposed sale of 5,000 shares valued at ~$1.49 million, representing less than 0.0014% of CME's market cap.
Risk Factors
- Form 144 is only an intent to sell; the sale may not be executed.
- Insider sales of equity compensation shares are routine and typically not indicative of negative outlook.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010430 |
| Document: 0001950047-26-010430-index.html | 0001950047-26-010430 |
| Document: 0001950047-26-010430.txt | 0001950047-26-010430 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 5d ago | Insider Cluster | $294.04 | awaiting T+60 | awaiting T+60 | $303.14 (+3.09%) |
Oct 27, 2026 5d ago | 144 | $294.04 | awaiting T+60 | awaiting T+60 | $303.14 (+3.09%) |
Oct 23, 2026 9d ago | Institutional Cluster | $305.71 | awaiting T+60 | awaiting T+60 | $303.14 (−0.84%) |
Oct 22, 2026 10d ago | 144 | $305.71 | awaiting T+60 | awaiting T+60 | $303.14 (−0.84%) |
Oct 22, 2026 10d ago | ANALYST-UPGRADE | $305.98 | awaiting T+60 | awaiting T+60 | $303.14 (−0.93%) |
Oct 21, 2026 11d ago | 8-K | No price | awaiting T+60 | awaiting T+60 | No price |
Oct 21, 2026 11d ago | Press Release | $295.79 | awaiting T+60 | awaiting T+60 | $303.14 (+2.48%) |
Oct 2, 2026 4w ago | ANALYST-UPGRADE | $263.14 | awaiting T+60 | awaiting T+60 | $303.14 (+15.20%) |
Sep 14, 2026 6w ago | Insider Cluster | $275.09 | awaiting T+60 | awaiting T+60 | $303.14 (+10.20%) |
Sep 14, 2026 6w ago | Insider Cluster | $275.09 | awaiting T+60 | awaiting T+60 | $303.14 (+10.20%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers